GSK exec accused of bribery

Share this article:

The former head of GlaxoSmithKline's China division has been accused of bribery. Bloomberg reports that Mark Reilly has been accused of ordering employees to bribe doctors, hospitals and medical groups to boost drug sales.

GSK told Bloomberg that they cooperating with authorities. The drugmaker noted earlier this year that corruption allegations have inflicted damage on regional sales.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.